Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23319176 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Subjects ≥ 70 Years
Condition: Prevention of : Herpes-Zoster
Intervention: Biological: Zostavax

Indicates status has not been verified in more than two years